Cancer Incidence and Mortality Estimates in Arab Countries in 2018: A GLOBOCAN Data Analysis

por Al-Muftah, Mariam, Al-Ejeh, Fares
Publicado 2023

Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors

por Al-Ejeh, Fares, Darby, Jocelyn M., Brown, Michael P.
Publicado 2009

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments

por Miranda, Mariska, Rozali, Esdy, Khanna, Kum Kum, Al-Ejeh, Fares
Publicado 2015

MITF and BRN2 contribute to metastatic growth after dissemination of melanoma

por Simmons, Jacinta L., Pierce, Carly J., Al-Ejeh, Fares, Boyle, Glen M.
Publicado 2017

RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy

por Wiegmans, Adrian P., Miranda, Mariska, Wen, Shu Wen, Al-Ejeh, Fares, Möller, Andreas
Publicado 2016

APOMAB®, a La-Specific Monoclonal Antibody, Detects the Apoptotic Tumor Response to Life-Prolonging and DNA-Damaging Chemotherapy

por Al-Ejeh, Fares, Darby, Jocelyn M., Tsopelas, Chris, Smyth, Douglas, Manavis, Jim, Brown, Michael P.
Publicado 2009

Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment

por Kalita-de Croft, Priyakshi, Straube, Jasmin, Lim, Malcolm, Al-Ejeh, Fares, Lakhani, Sunil R., Saunus, Jodi M.
Publicado 2019

G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome

por Casciello, Francesco, Al-Ejeh, Fares, Miranda, Mariska, Kelly, Greg, Baxter, Eva, Windloch, Karolina, Gannon, Frank, Lee, Jason S
Publicado 2020

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia

por Charmsaz, Sara, Beckett, Kirrilee, Smith, Fiona M., Bruedigam, Claudia, Moore, Andrew S., Al-Ejeh, Fares, Lane, Steven W., Boyd, Andrew W.
Publicado 2015

The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®

por Staudacher, Alexander H, Al-Ejeh, Fares, Fraser, Cara K, Darby, Jocelyn M, Roder, David M, Ruszkiewicz, Andrew, Manavis, Jim, Brown, Michael P
Publicado 2014

Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome

por Neilsen, Paul M., Noll, Jacqueline E., Suetani, Rachel J., Schulz, Renee B., Al-Ejeh, Fares, Evdokiou, Andreas, Lane, David P., Callen, David F.
Publicado 2011

Differential gene expression of tumor-infiltrating CD4(+) T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis

por Sasidharan Nair, Varun, Saleh, Reem, Taha, Rowaida Z, Toor, Salman M, Murshed, Khaled, Ahmed, Ayman A, Kurer, Mohamed A, Abu Nada, Mohamed, Al Ejeh, Fares, Elkord, Eyad
Publicado 2020

Differential gene expression of tumor-infiltrating CD8(+) T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis

por Saleh, Reem, Sasidharan Nair, Varun, Toor, Salman M, Taha, Rowaida Z, Murshed, Khaled, Al-Dhaheri, Mahmood, Khawar, Mahwish, Petkar, Mahir Abdulla, Abu Nada, Mohamed, Al-Ejeh, Fares, Elkord, Eyad
Publicado 2020

Rad51 supports triple negative breast cancer metastasis

por Wiegmans, Adrian P, Al-Ejeh, Fares, Chee, Nicole, Yap, Pei-Yi, Gorski, Julia J, Silva, Leonard Da, Bolderson, Emma, Chenevix-Trench, Georgia, Anderson, Robin, Simpson, Peter T, Lakhani, Sunil R, Khanna, Kum Kum
Publicado 2014

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

por Al-Ejeh, Fares, Miranda, Mariska, Shi, Wei, Simpson, Peter T., Song, Sarah, Vargas, Ana Cristina, Saunus, Jodi M., Smart, Chanel E., Mariasegaram, Mythily, Wiegmans, Adrian P., Chenevix-Trench, Georgia, Lakhani, Sunil R., Khanna, Kum Kum
Publicado 2014

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases

por Kalita-de Croft, Priyakshi, Lim, Malcolm, Chittoory, Haarika, de Luca, Xavier M., Kutasovic, Jamie R., Day, Bryan W., Al-Ejeh, Fares, Simpson, Peter T., McCart Reed, Amy E., Lakhani, Sunil R., Saunus, Jodi M.
Publicado 2020

Essential Developmental, Genomic Stability, and Tumour Suppressor Functions of the Mouse Orthologue of hSSB1/NABP2

por Shi, Wei, Bain, Amanda L., Schwer, Bjoern, Al-Ejeh, Fares, Smith, Corey, Wong, Lee, Chai, Hua, Miranda, Mariska S., Ho, Uda, Kawaguchi, Makoto, Miura, Yutaka, Finnie, John W., Wall, Meaghan, Heierhorst, Jörg, Wicking, Carol, Spring, Kevin J., Alt, Frederick W., Khanna, Kum Kum
Publicado 2013

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma

por Offenhäuser, Carolin, Al-Ejeh, Fares, Puttick, Simon, Ensbey, Kathleen S., Bruce, Zara C., Jamieson, Paul R., Smith, Fiona M., Stringer, Brett W., Carrington, Benjamin, Fuchs, Adrian V., Bell, Craig A., Jeffree, Rosalind, Rose, Stephen, Thurecht, Kristofer J., Boyd, Andrew W., Day, Bryan W.
Publicado 2018

Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells

por Genz, Berit, Coleman, Miranda A., Irvine, Katharine M., Kutasovic, Jamie R., Miranda, Mariska, Gratte, Francis D., Tirnitz-Parker, Janina E. E., Olynyk, John. K., Calvopina, Diego A., Weis, Anna, Cloonan, Nicole, Robinson, Harley, Hill, Michelle M., Al-Ejeh, Fares, Ramm, Grant A.
Publicado 2019

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefi...

por Bessette, Darrell C., Tilch, Erik, Seidens, Tatjana, Quinn, Michael C. J., Wiegmans, Adrian P., Shi, Wei, Cocciardi, Sibylle, McCart-Reed, Amy, Saunus, Jodi M., Simpson, Peter T., Grimmond, Sean M., Lakhani, Sunil R., Khanna, Kum Kum, Waddell, Nic, Al-Ejeh, Fares, Chenevix-Trench, Georgia
Publicado 2015